REVAPP Trademark

Trademark Overview


On Thursday, November 10, 2016, a trademark application was filed for REVAPP with the United States Patent and Trademark Office. The USPTO has given the REVAPP trademark a serial number of 87232950. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 21, 2020. This trademark is owned by Celgene Corporation. The REVAPP trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:

Computer application software for mobile phones, portable media players, handheld computers, namely, software for use in database management, for use in electronic storage of data, for use as a spreadsheet, and for word processing, all for use by patients and health care professionals in connection with providing medical counseling and medical information in the field of lenalidomide and safety issues pertaining to lenalidomide; downloadable software in the nature of a mobile application for use in database management, for use as a spreadsheet, for word processing, for electronic storage of data, in connection with providing medical counseling and medical information in the field of lenalidomide and safety issues pertaining to lenalidomide; computer software for use on mobile and cellular phones in the field of health care and dosing of pharmaceuticals for use in accessing databases and websites in order to provide drug dosage and administration information in the field of lenalidomide...

Software as a service (SAAS) featuring software for tracking and monitoring medication intake and safety issues pertaining to lenalidomide, all for use by patients and health care professionals in connection with providing medical counseling and medical information in the field of lenalidomide and safety issues pertaining to lenalidomide; providing information about the results of clinical trials for pharmaceutical products; providing temporary use of non downloable online software applications containing information on the use of pharmaceutical products and for calculating use of medicine in the field of lenalidomide and safety issues pertaining to lenalidomide; providing temporary use of non-downloadable electronic software for use on mobile and cellular phones, handheld computers in the field of health care and dosing of pharmaceuticals for use in accessing databases and websites in order to provide drug dosage and administration information in the field of lenalidomide and safety i...
revapp

General Information


Serial Number87232950
Word MarkREVAPP
Filing DateThursday, November 10, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 21, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 20, 2017

Trademark Statements


Goods and ServicesComputer application software for mobile phones, portable media players, handheld computers, namely, software for use in database management, for use in electronic storage of data, for use as a spreadsheet, and for word processing, all for use by patients and health care professionals in connection with providing medical counseling and medical information in the field of lenalidomide and safety issues pertaining to lenalidomide; downloadable software in the nature of a mobile application for use in database management, for use as a spreadsheet, for word processing, for electronic storage of data, in connection with providing medical counseling and medical information in the field of lenalidomide and safety issues pertaining to lenalidomide; computer software for use on mobile and cellular phones in the field of health care and dosing of pharmaceuticals for use in accessing databases and websites in order to provide drug dosage and administration information in the field of lenalidomide; downloadable electronic software for use on mobile and cellular phones, handheld computers in the field of health care and dosing of pharmaceuticals for use in accessing databases and websites in order to provide drug dosage and administration information in the field of lenalidomide; computer application software for mobile phones, portable media players, handheld computers, namely, software for use in database management, for use in electronic storage of data, for use as a spreadsheet, and for word processing, all for use by patients and health care professionals in connection with providing medical counseling and medical information in the field of lenalidomide and safety issues pertaining to lenalidomide
Goods and ServicesSoftware as a service (SAAS) featuring software for tracking and monitoring medication intake and safety issues pertaining to lenalidomide, all for use by patients and health care professionals in connection with providing medical counseling and medical information in the field of lenalidomide and safety issues pertaining to lenalidomide; providing information about the results of clinical trials for pharmaceutical products; providing temporary use of non downloable online software applications containing information on the use of pharmaceutical products and for calculating use of medicine in the field of lenalidomide and safety issues pertaining to lenalidomide; providing temporary use of non-downloadable electronic software for use on mobile and cellular phones, handheld computers in the field of health care and dosing of pharmaceuticals for use in accessing databases and websites in order to provide drug dosage and administration information in the field of lenalidomide and safety issues pertaining to lenalidomide; providing online, non-downloadable computer application software for mobile phones, portable media players, handheld computers, namely, software for use in database management, for use in electronic storage of data, for use as a spreadsheet, and for word processing, all for use by patients and health care professionals in connection with providing medical counseling and medical information in the field of lenalidomide and safety issues pertaining to lenalidomide

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateThursday, November 17, 2016
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 17, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events


Event DateEvent Description
Monday, September 21, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 21, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, December 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 26, 2019EXTENSION 5 GRANTED
Monday, December 16, 2019EXTENSION 5 FILED
Thursday, December 26, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 16, 2019TEAS EXTENSION RECEIVED
Monday, July 8, 2019ASSIGNED TO EXAMINER
Tuesday, June 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 7, 2019EXTENSION 4 GRANTED
Friday, June 7, 2019EXTENSION 4 FILED
Friday, June 7, 2019TEAS EXTENSION RECEIVED
Saturday, December 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 6, 2018EXTENSION 3 GRANTED
Thursday, December 6, 2018EXTENSION 3 FILED
Thursday, December 6, 2018TEAS EXTENSION RECEIVED
Wednesday, July 18, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 16, 2018EXTENSION 2 GRANTED
Monday, July 16, 2018EXTENSION 2 FILED
Monday, July 16, 2018TEAS EXTENSION RECEIVED
Thursday, January 18, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 16, 2018EXTENSION 1 GRANTED
Tuesday, January 16, 2018EXTENSION 1 FILED
Tuesday, January 16, 2018TEAS EXTENSION RECEIVED
Tuesday, August 15, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 20, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 20, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 31, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 10, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 19, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 18, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 18, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 13, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 13, 2017NON-FINAL ACTION E-MAILED
Friday, January 13, 2017NON-FINAL ACTION WRITTEN
Friday, January 6, 2017ASSIGNED TO EXAMINER
Thursday, November 17, 2016TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Thursday, November 17, 2016TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, November 17, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 14, 2016NEW APPLICATION ENTERED IN TRAM